Crossmark

Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction

Crossref DOI link: https://doi.org/10.1016/j.bjid.2023.102757

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Matsuda, Elaine Monteiro http://orcid.org/0000-0002-0254-4154
Campos, Ivana Barros http://orcid.org/0000-0003-0334-0572
de Oliveira, Isabela Penteriche http://orcid.org/0000-0003-2202-0443
Colpas, Daniela Rodrigues http://orcid.org/0000-0002-5901-2095
López-Lopes, Giselle Ibete Silva http://orcid.org/0000-0002-4564-3208
Chiavegato, Victor Oliveira http://orcid.org/0000-0002-3948-743X
Brígido, Luís Fernando de Macedo http://orcid.org/0000-0002-1022-7837
License Information

Text and Data Mining valid from 2023-05-01

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-02-08
More Information

This article is maintained by: Elsevier

Article Title: Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2023.102757

Content Type: article

Copyright: © 2023 Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Infectologia.

Document is current

Any future updates will be listed below